Uterine fibroids – discover the symptoms, their impact on fertility, diagnostics, and modern treatment methods. Learn how to care for your reproductive health.
Table of Contents
- What Are Uterine Fibroids? Key Facts
- Most Common Symptoms of Uterine Fibroids – What Should Be Concerning?
- How Do Uterine Fibroids Affect Fertility and Pregnancy?
- Diagnostics of Fibroids – Examinations and Gynecological Consultations
- Uterine Fibroid Treatment Methods – From Pharmacology to Surgery
- When to Remove Fibroids? Prevention, Complications, and Recovery
What Are Uterine Fibroids? Key Facts
Uterine fibroids, also known as fibromas or leiomyomas, are among the most common benign (non-cancerous) tumors of the female reproductive system in women of reproductive age. They are clusters of smooth muscle cells and connective tissue developing within the uterine wall. Fibroids can vary in size – from microscopic, measuring only a few millimeters in diameter, to large tumors reaching several, or even dozens of centimeters. Based on location, they are classified as submucosal (growing toward the uterine cavity), intramural (growing within the muscular wall), and subserosal (protruding outside the uterus). Their presence is not associated with malignancy, and the risk of cancerous transformation is very low (below 1%). Uterine fibroids most commonly appear in women between the ages of 30 and 50, with risk factors including genetic predisposition, hormonal disorders (especially estrogen excess), history of obesity, hypertension, lack of pregnancies, or late motherhood. It is estimated that even 20-40% of women of reproductive age may have fibroids, though many remain asymptomatic for a long time and are discovered incidentally during routine ultrasound or gynecological exams.
The pathogenesis of uterine fibroids is complex, but hormonal and genetic factors play a crucial role. Due to the presence of estrogen and progesterone-sensitive receptors, fibroids grow mainly under the influence of these hormones, which explains their higher frequency in women of reproductive age and tendency for regression after menopause. Most fibroids grow slowly, although some may rapidly increase in size, especially during periods of significant hormonal fluctuations (e.g., pregnancy). Degenerative changes within fibroids, such as calcification, necrosis, or hyalinization, can affect their imaging results and treatment choice. Uterine fibroids rarely occur in girls before puberty, and their appearance in postmenopausal women requires special diagnostics. Unlike malignant changes, fibroids do not infiltrate adjacent tissues but may compress neighboring organs (e.g., bladder, rectum), leading to symptoms such as frequent urination, pressure sensation, pelvic pain and discomfort, or defecation disturbances. Large or unfavorably positioned fibroids can cause serious health complications, including fertility issues, irregular and heavy menstrual bleeding, anemia, or miscarriages. Despite their benign nature, fibroids pose a significant clinical and social problem, affecting quality of life, physical and psychological comfort, and decisions regarding family planning and gynecological treatments. Understanding the mechanisms and risk factors of uterine fibroids is crucial for prevention, effective diagnostics, and implementation of modern, personalized treatments for this common women’s disease.
Most Common Symptoms of Uterine Fibroids – What Should Be Concerning?
Uterine fibroids can remain asymptomatic for a long time, meaning many women are unaware of their presence until symptoms arise or they are detected incidentally during a gynecological examination. Symptoms of fibroids vary depending on their location, size, number, growth rate, and individual susceptibility. One of the most commonly reported symptoms is heavy, prolonged menstrual bleeding (menorrhagia), which can lead to iron-deficiency anemia. Bleeding often exceeds seven days, is more intense than usual, and women report frequent necessity to change sanitary pads or tampons, even at night. There may also be intermenstrual bleeding or spotting, which is distressing and affects daily comfort. Another key symptom is lower abdominal pain, perceived as dull, persistent, or colicky, often radiating to the lumbar or thigh area. In cases of large or numerous fibroids, there may be the sensation of pressure, fullness, or even abdominal distension, sometimes misinterpreted as weight gain or bloating. Some women describe the sensation of a “heavy abdomen,” especially during physical activity or while urinating or defecating.
Symptoms related to the pressure exerted by fibroids on adjacent organs – the bladder or rectum – should also be concerning. Subserosal or cervical fibroids may lead to frequent urination, bladder pressure, difficulty emptying the bladder, or even incomplete emptying. Some women experience increased urgency to move the bowels, constipation, and in cases of significant tumor enlargement – painful defecation. Lower back and sacral pain can occur due to pelvic nerve pressure. Submucosal fibroids, in particular, can affect fertility and pregnancy course, causing difficulties in conceiving, recurrent miscarriages, as well as fetal development abnormalities and premature births. Some patients experience chronic fatigue and weakness due to blood loss and associated anemia. In rare cases, acute symptoms such as severe lower abdominal pain and fever may occur as a result of fibroid torsion or necrosis, requiring immediate medical attention. Any of these symptoms – especially intermenstrual bleeding, unusually heavy periods, prolonged abdominal pain, urinary or bowel disturbances, and trouble conceiving – should prompt a visit to a gynecologist for diagnostic tests. Early detection and appropriate treatment are crucial for preserving reproductive health and overall quality of life.
How Do Uterine Fibroids Affect Fertility and Pregnancy?

The impact of uterine fibroids on fertility and pregnancy course is complex and depends mainly on their number, location, and size. Submucosal fibroids and large intramural changes are most important as they can mechanically disturb the uterine cavity anatomy, making embryo implantation difficult or limiting the space for a growing fetus. Submucosal fibroids protruding into the uterine cavity are especially detrimental to fertility – they can cause infertility, recurrent miscarriages, and chronic endometrial inflammation, hindering embryo implantation. Moreover, intramural fibroids larger than 4 cm, as well as multiple uterine wall changes, may disrupt myometrial contractility, impairing sperm transport and increasing the risk of complications during assisted reproduction techniques like IVF. Even small fibroids can induce chronic inflammation or disrupt local endometrial blood supply, negatively impacting endometrial receptivity and hormone processes essential for conception. Often, women struggling with infertility are diagnosed with fibroids, though they are not always the sole cause of infertility – a personalized approach and proper diagnostics are required to determine if the changes are truly impairing reproductive function.
The presence of uterine fibroids can significantly impact not only conception but also the further course and outcome of pregnancy. Fibroids increase the risk of pregnancy complications including miscarriage, preterm labor, abnormal fetal position, placental abruption, or fetal growth restriction. They are also associated with more frequent cesarean sections and postpartum complications such as uterine atony and increased bleeding risk. During pregnancy, fibroids may enlarge due to intense hormonal stimulation, sometimes resulting in painful episodes known as “red degeneration” – characterized by acute abdominal pain and inflammatory reactions. On the other hand, in many cases, fibroids do not cause significant complications and pregnancy may progress normally. However, every patient diagnosed with changes should remain under close gynecological supervision. Notably, modern diagnostics using ultrasound, hysteroscopy, and MRI allow for more precise identification of changes threatening fertility and the implementation of individually tailored therapies – from pharmacological treatments, through minimally invasive procedures, to classical surgery. This increases the possibility of becoming and carrying a pregnancy to term even in women with fibroids. The decision regarding treatment and method selection should always be made jointly with the physician, factoring in all aspects affecting fertility, the woman’s health, and family planning.
Diagnostics of Fibroids – Examinations and Gynecological Consultations
The process of diagnosing uterine fibroids is multi-staged, including a detailed medical history, imaging studies, and assessment of the patient’s overall health. The first step during a gynecological consultation is a conversation regarding menstrual history, length and intensity of bleeding, the presence of additional pain symptoms, or trouble conceiving. The doctor considers risk factors such as age, genetic load, history of pregnancies, previous gynecological surgery, and comorbidities. A key aspect is the gynecological examination, allowing evaluation of the uterus’s size, shape, and firmness, as well as potential abnormalities. The presence of an enlarged, non-homogeneous, or deformed uterus often suggests fibroid tumors, especially if the patient reports typical symptoms such as heavy periods, intermenstrual bleeding, or chronic pelvic pain. Initial diagnosis via physical examination, however, requires confirmation by appropriate imaging methods, enabling precise assessment of the distribution, size, and number of fibroids and their impact on uterine structure or adjacent organs.
The primary diagnostic method is a transvaginal ultrasound (TVUS), which, due to its high image resolution, allows detection of even small changes and accurate localization of submucosal, intramural, and subserosal fibroids. Transvaginal ultrasound is especially effective for slim women and in the case of small fibroids, while in women with a significantly enlarged uterus or numerous changes, doctors may opt for an abdominal ultrasound to better visualize the entire pelvis. In selected cases, if the ultrasound image is unclear or very precise anatomical imaging is required, magnetic resonance imaging (MRI) is recommended, allowing for assessment of size, number, tumor relation to uterine walls, endometrial layer, and possible adjacent tissue infiltration. MRI is especially useful before planned surgery, in risk assessment for complications, and differentiating fibroids from other pelvic pathologies. In some patients, the doctor may order diagnostic hysteroscopy, in which, using a thin endoscope, the uterine cavity is assessed directly and material can be taken for histopathology – this is especially important in suspected submucosal changes or atypical bleeding. Hysteroscopy allows visualization of fibroids and precise planning of further conservative or surgical treatment. Differential diagnostics also include blood markers such as CBC (to detect anemia due to excessive bleeding) and, in the case of suspected malignancy, tumor markers. In certain situations, especially with atypical symptoms or suspicion of cancer, the doctor may order additional laboratory tests or an oncology consultation. Collaborative care with other specialists is often necessary – for example, an endocrinology evaluation in case of hormonal disturbances or consulting a radiologist about the best imaging method. Thanks to technological progress, modern diagnostics of uterine fibroids is fast, effective, and safe for patients, allowing tailored treatment and improved effectiveness for both conservative, pharmacological, and surgical therapies.
Uterine Fibroid Treatment Methods – From Pharmacology to Surgery
The choice of treatment for uterine fibroids depends on many factors, including the size, number, and location of changes, symptom severity, the patient’s reproductive plans, age, and overall health. Therapy can include both conservative and surgical interventions, with increasing emphasis on individualized therapy and minimizing reproductive risks. Pharmacological treatment is most commonly recommended for patients with small, asymptomatic fibroids or temporarily – e.g., before planned surgery. Gonadotropin-releasing hormone (GnRH) analogs are primarily used, causing temporary suppression of estrogen, reducing tumor volume and alleviating symptoms like bleeding and menstrual pain. Another drug group includes selective progesterone receptor modulators (e.g., ulipristal acetate), which can limit fibroid growth and stabilize the menstrual cycle. Additionally, symptomatic management uses painkillers, NSAIDs, and iron supplements in cases of anemia. For unstable or very bothersome symptoms, surgical methods are often used, while pharmacotherapy is sometimes aimed at shrinking fibroids and reducing intraoperative bleeding to prepare for surgery. Medication has limitations – it does not provide permanent cure, and after discontinuation, fibroids usually return to their original size, so it is treated as one stage in a comprehensive treatment plan. There are also local methods, such as intrauterine progestogen-releasing systems (IUS), which can help control bleeding in women not planning children soon.
If pharmacological therapy is ineffective or contraindicated, a doctor may suggest more advanced surgical options. The gold standard is myomectomy (surgical removal of fibroids while preserving the uterus) – especially recommended for women planning pregnancies, as it is the least invasive intervention in the reproductive organ’s structure. Myomectomy can be performed laparoscopically (via small incisions and a camera), hysteroscopically (transvaginally, for submucosal fibroids), or traditionally via laparotomy, which is reserved for the largest or most numerous tumors. Another option is uterine artery embolization – a minimally invasive technique where the blood vessels supplying the fibroid are occluded, causing the tumor to die and shrink, alleviating symptoms. This procedure does not require surgical incisions, has a short recovery time, and is recommended especially for patients unfit for surgery or who do not plan more pregnancies. Increasingly, innovative ablative techniques are being used, such as percutaneous high-frequency focused ultrasound ablation (HIFU), allowing precise fibroid destruction without surgery and with uterine preservation. In advanced cases, ineffective myomectomies, and lack of reproductive plans, hysterectomy (complete uterine removal) is considered – the only method guaranteeing permanent cure but resulting in loss of fertility. Each method requires individual risk-benefit assessment, and the chosen surgical technique should consider not only the nature of the changes, but also overall health, patient expectations, and the possibility of outpatient treatment. Advances in technology and specialist experience now allow for reduced hospitalization, improved surgical safety, and a quicker return to daily activities.
When to Remove Fibroids? Prevention, Complications, and Recovery
The decision to remove uterine fibroids depends on various factors, including the severity of symptoms, location and size of the changes, patient’s age, plans for motherhood, and general health. Not every presence of fibroids requires surgical intervention – estimates show that even half of these benign tumors cause no symptoms and are discovered incidentally during routine gynecological exams. Small, asymptomatic fibroids without pain, bleeding, or pressure on surrounding organs are usually just observed. Removal is typically advised when complications occur – the most common indications being heavy, prolonged menstrual bleeding causing anemia, severe lower abdominal pain, significant abdominal enlargement, rapid tumor growth, and symptoms from pressure on adjacent organs, such as frequent urination, urinary difficulty, or chronic constipation. Rapid intervention is also recommended for submucosal fibroids, especially if they cause infertility, recurrent miscarriages, or hinder embryo implantation. Women planning pregnancy in the near future may be eligible for surgical treatment – in their case, less invasive operative methods are usually preferred, like myomectomy. Unlike hysterectomy (which results in permanent infertility), myomectomy preserves the uterus and provides the chance for future motherhood. Treatment decisions should always be individual and preceded by comprehensive diagnostics. Although rare, fibroids may lead to complications such as torsion, necrosis, infection, or life-threatening hemorrhage – requiring strict cooperation with a doctor and regular follow-up visits. Some women fear surgery; however, timely intervention often prevents serious complications and the need for more extensive procedures in the future.
Effective prevention of uterine fibroids is not always possible due to their complex etiology, but certain actions can reduce the risk of development and progression. Key roles are played by regular gynecological care (enabling early detection of abnormalities), healthy lifestyle, a fiber-rich diet, avoiding excess weight and obesity, physical activity, and reducing stress affecting hormone levels. It’s proven that hormonal factors – especially high estrogen levels – have a key influence on fibroid development, so weight management and proper diet are fundamental. Early response to symptoms such as increasing bleeding or pain is also important, and regular transvaginal ultrasound after age 30 helps early identification of new changes. Recovery after fibroid treatment, especially surgery, varies depending on the method used. Modern minimally invasive techniques, such as laparoscopy or hysteroscopy, significantly shorten recovery time – most patients return to daily activities within several days or a week after the procedure. For classical open surgery, regaining full fitness may take several to even more than a dozen weeks, and during that period, it’s crucial to follow medical advice, use painkillers, gradually resume physical activity, and avoid excessive exertion. Post-surgical patients should also care for their mental health – conversations with loved ones, support groups, and professional psychological care help restore emotional balance. Monitoring for recurrences is also important; therefore, after fibroid treatment, systematic control visits and health monitoring are necessary. With proper rehabilitation, prevention, and regular checkups, the risk of complications can be minimized, ensuring long-term reproductive health.
Summary
Uterine fibroids are common, yet benign, conditions that can significantly affect women’s comfort and fertility. Recognizing the symptoms and prompt diagnostics are crucial for effective treatment. Thanks to medical advances, there are effective treatment options for fibroids – both pharmacological and surgical – helping maintain health and the chance to have a child. Remember to consult your gynecologist regularly, especially if you experience any worrying symptoms. Prevention and awareness of the risks associated with fibroids are the foundation of reproductive system health.